$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

$mlss Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000143774919016799 Filed on August 14, 2019

Income Statement

Concept	2019 Q2	2018 Q2
Revenue	$2.258M	$2.428M
YoY Change	-7.03%	-3.77%
Cost Of Revenue	$752.2K	$1.022M
YoY Change	-26.37%	16.94%
Gross Profit	$1.506M	$1.407M
YoY Change	7.02%	-14.74%
Gross Profit Margin	66.69%	57.93%
Selling, General & Admin	$2.518M	$2.822M
YoY Change	-10.77%	-8.46%
% of Gross Profit	167.23%	200.57%
Research & Development	$95.53K	$9.775K
YoY Change	877.28%	-91.86%
% of Gross Profit	6.34%	0.69%
Depreciation & Amortization	$25.46K	$245.1K
YoY Change	-89.62%	669.75%
% of Gross Profit	1.69%	17.42%
Operating Expenses	$2.613M	$2.832M
YoY Change	-7.7%	-11.58%
Operating Profit	-$1.108M	-$1.425M
YoY Change	-22.24%	-8.23%
Interest Expense	$12.65K	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$2.563K	-$1.756K
YoY Change	45.96%	71.48%
Pretax Income	-$1.098M	-$1.425M
YoY Change	-22.94%	-8.17%
Income Tax	$14.16K	$4.075K
% Of Pretax Income
Net Earnings	-$1.041M	-$1.343M
YoY Change	-22.47%	-9.18%
Net Earnings / Revenue	-46.12%	-55.3%
Basic Earnings Per Share	-$0.02	-$0.04
Diluted Earnings Per Share	-$0.02	-$0.04
COMMON SHARES
Basic Shares Outstanding	45.37M	35.30M
Diluted Shares Outstanding	45.37M	35.30M

Balance Sheet

Concept	2019 Q2	2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.338M	$870.0K
YoY Change	168.69%	-70.51%
Cash & Equivalents	$2.338M	$865.7K
Short-Term Investments
Other Short-Term Assets	$499.4K	$2.280M
YoY Change	-78.1%	145.16%
Inventory	$1.270M	$2.310M
Prepaid Expenses
Receivables	$1.659M	$1.840M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$6.296M	$10.98M
YoY Change	-42.64%	-4.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$65.67K	$105.5K
YoY Change	-37.77%	-38.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$17.36K	$26.88K
YoY Change	-35.43%	0.0%
Total Long-Term Assets	$491.8K	$2.453M
YoY Change	-79.95%	53.54%
TOTAL ASSETS
Total Short-Term Assets	$6.296M	$10.98M
Total Long-Term Assets	$491.8K	$2.453M
Total Assets	$6.788M	$13.43M
YoY Change	-49.45%	2.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.193M	$1.365M
YoY Change	-12.65%	38.53%
Accrued Expenses	$1.465M	$1.938M
YoY Change	-24.4%	17.28%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.951M	$8.110M
YoY Change	-26.62%	100.96%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$0.00
YoY Change		-100.0%
Total Long-Term Liabilities	$0.00	$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.951M	$8.110M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$5.951M	$8.110M
YoY Change	-26.62%	49.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$87.82M	-$81.78M
YoY Change	7.38%	8.52%
Common Stock	$89.61M	$87.87M
YoY Change	1.98%	5.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$911.5K	$911.5K
YoY Change	0.0%	0.0%
Treasury Stock Shares	$33.33K	$33.33K
Shareholders Equity	$871.2K	$5.171M
YoY Change
Total Liabilities & Shareholders Equity	$6.788M	$13.43M
YoY Change	-49.45%	2.54%

Cashflow Statement

Concept	2019 Q2	2018 Q2
OPERATING ACTIVITIES
Net Income	-$1.041M	-$1.343M
YoY Change	-22.47%	-9.18%
Depreciation, Depletion And Amortization	$25.46K	$245.1K
YoY Change	-89.62%	669.75%
Cash From Operating Activities	-$402.1K	-$980.0K
YoY Change	-58.97%	1125.0%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-250.0K
YoY Change	-100.0%	-292.31%
NET CHANGE
Cash From Operating Activities	-402.1K	-980.0K
Cash From Investing Activities	0.000	0.000
Cash From Financing Activities	0.000	-250.0K
Net Change In Cash	-402.1K	-1.230M
YoY Change	-67.31%	-12400.0%
FREE CASH FLOW
Cash From Operating Activities	-$402.1K	-$980.0K
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$402.1K	-$980.0K
YoY Change	-58.97%	2350.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000855683
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47490155
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Registrant Name EntityRegistrantName	MILESTONE SCIENTIFIC INC.
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	mlss
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019Q2	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	125428
CY2018Q4	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty
CY2005Q1	mlss	Additional Percentage Of Director Compensation On Sales Value Using Certain Specify Technology AdditionalPercentageOfDirectorCompensationOnSalesValueUsingCertainSpecifyTechnology	0.025
CY2005Q1	mlss	Additional Percentage Of Director Compensation Sales Value Using Other Kind Of Technology AdditionalPercentageOfDirectorCompensationSalesValueUsingOtherKindOfTechnology	0.05
CY2018Q1	mlss	Adjustment To Equity Related To Asset Acquisition AdjustmentToEquityRelatedToAssetAcquisition	-1975370
	mlss	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets	79109
	mlss	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets
	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod
	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	1749171
	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.50
CY2019Q2	mlss	Common Stock Shares To Be Issued CommonStockSharesToBeIssued	2900000
CY2019Q2	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	372700
CY2018Q4	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	421800
	mlss	Derivative Liability Assumed DerivativeLiabilityAssumed	1471585
	mlss	Derivative Liability Assumed DerivativeLiabilityAssumed
CY2019Q2	mlss	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	1423353
CY2018Q2	mlss	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	1119440
	mlss	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	3302057
	mlss	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	2371652
CY2019Q2	mlss	Equity Securities Issued EquitySecuritiesIssued	4850000
CY2019Q2	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment
CY2018Q4	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	1539794
	mlss	Gain Loss On Liability Classified Shares To Be Issued GainLossOnLiabilityClassifiedSharesToBeIssued	47000
CY2019Q2	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1111907
CY2018Q2	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1428592
	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1895538
	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3440745
	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	125428
	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties
	mlss	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	79109
	mlss	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset
	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	-118669
	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	164590
	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments	249749
CY2019Q1	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	61500
CY2018Q1	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	339500
CY2018Q2	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	60000
CY2019Q2	mlss	Stock Issued During Period Value Mandatory Conversion Of Preferred Shares To Common Stock StockIssuedDuringPeriodValueMandatoryConversionOfPreferredSharesToCommonStock
	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation	22500
	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation
	mlss	Stock Issued For Public Offering StockIssuedForPublicOffering	61500
	mlss	Stock Issued For Public Offering StockIssuedForPublicOffering	399500
	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm	P4Y219D
	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P175D
	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P2Y219D
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1192823
	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	-166292
	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred
	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability	166292
	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability
CY2015Q2	mlss	Operating Leases Monthly Rent Expense OperatingLeasesMonthlyRentExpense	12522
	mlss	Percentage Of Valuation Allowance PercentageOfValuationAllowance	1
	mlss	Proceeds From Sale Of Variable Interest Entity Shares With Agreement To Repurchase ProceedsFromSaleOfVariableInterestEntitySharesWithAgreementToRepurchase
	mlss	Proceeds From Sale Of Variable Interest Entity Shares With Agreement To Repurchase ProceedsFromSaleOfVariableInterestEntitySharesWithAgreementToRepurchase	-250000
CY2019Q1	mlss	Reclassification Of Warrants And Shares To Be Issued ReclassificationOfWarrantsAndSharesToBeIssued	-406045
CY2019Q2	mlss	Reclassification Of Warrants And Shares To Be Issued ReclassificationOfWarrantsAndSharesToBeIssued	-1065539
	mlss	Sale Of Variable Interest Entitys Shares SaleOfVariableInterestEntitysShares
	mlss	Sale Of Variable Interest Entitys Shares SaleOfVariableInterestEntitysShares	-1400000
	mlss	Shares Issue To Board Of Directors For Services Rendered SharesIssueToBoardOfDirectorsForServicesRendered	37000
	mlss	Shares Issue To Board Of Directors For Services Rendered SharesIssueToBoardOfDirectorsForServicesRendered
	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments	180000
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1205396
CY2019Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1283367
CY2018Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	648783
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2018Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1663849
CY2019Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	89559585
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	88414718
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	56988
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	44712
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	86809
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	84092
CY2019Q2	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	530114
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1658919
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1978456
CY2019Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent
CY2018Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	100000
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1464846
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1481715
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26506
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	469356
CY2019Q2	us-gaap	Assets Assets	6788289
CY2018Q4	us-gaap	Assets Assets	6400968
CY2019Q2	us-gaap	Assets Current AssetsCurrent	6296499
CY2018Q4	us-gaap	Assets Current AssetsCurrent	5856260
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2337593
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	743429
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2636956
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	865654
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1594164
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1771302
CY2018Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.55
CY2019Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.48
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1592775
CY2019Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3341946
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47132220
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33859034
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	51501
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	510118
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47098886
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33825701
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	47132
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	36330
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	100000
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	752183
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1021573
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1370876
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1584250
CY2019Q2	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	0
CY2018Q4	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	2470565
CY2019Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent
CY2018Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	50000
	us-gaap	Depreciation Depreciation	24993
	us-gaap	Depreciation Depreciation	40762
CY2019Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25456
CY2018Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	245127
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	15191133
CY2019Q2	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-598179
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-442201
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-2107655
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-1385070
CY2019Q2	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	1149474
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	1328079
CY2019Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1418863
CY2018Q4	us-gaap	Derivative Liabilities DerivativeLiabilities
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2019Q2	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	18941168
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	15191133
CY2019Q2	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	324300
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	650840
	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	559400
	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	1098452
CY2019Q2	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	23276964
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	17696033
CY2019Q2	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	-4335796
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	-2504900
CY2019Q2	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	825174
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	677239
	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	1194402
	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	986582
CY2019Q2	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	18941168
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	1753802
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	2085034
CY2019Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	969096
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2042443
CY2019Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4017510
CY2019Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	408767
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	435273
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	52722
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
CY2019Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	12462
CY2018Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
CY2019Q2	us-gaap	Gross Profit GrossProfit	1505668
CY2018Q2	us-gaap	Gross Profit GrossProfit	1406925
	us-gaap	Gross Profit GrossProfit	2802883
	us-gaap	Gross Profit GrossProfit	2649853
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1500000
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1097744
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1424517
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1876911
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	243360
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-319537
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	304632
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-100000
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	1092540
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-380482
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3425207
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	49100
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	115374
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	58664
CY2018Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	78591
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14163
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4075
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18627
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15538
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12573
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	511632
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	284128
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	623014
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-99997
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1092540
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-50000
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	686365
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-652631
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-778530
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-9523
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7978
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	48343
CY2019Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	188
CY2018Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1926
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1207
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4590
CY2019Q2	us-gaap	Inventory Net InventoryNet	1270480
CY2018Q4	us-gaap	Inventory Net InventoryNet	1921051
CY2019Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	754000
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	763000
CY2019Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	81544
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	123918
	us-gaap	Inventory Write Down InventoryWriteDown	-2061
	us-gaap	Inventory Write Down InventoryWriteDown	290349
CY2019Q2	us-gaap	Lease Cost LeaseCost	39554
	us-gaap	Lease Cost LeaseCost	79109
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	95085
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	15976
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	79109
CY2019Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2255
CY2019Q2	us-gaap	Liabilities Liabilities	5950857
CY2018Q4	us-gaap	Liabilities Liabilities	4872760
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6788289
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6400968
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5950857
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4872760
CY2019Q2	us-gaap	Minority Interest MinorityInterest	-33804
CY2018Q4	us-gaap	Minority Interest MinorityInterest	-11402
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2224547
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-250000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8104
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4531
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-622279
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1516771
	us-gaap	Operating Expenses OperatingExpenses	4728898
	us-gaap	Operating Expenses OperatingExpenses	6076193
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1107831
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4531
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8104
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-1041284
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-1343007
	us-gaap	Net Income Loss NetIncomeLoss	-1824036
	us-gaap	Net Income Loss NetIncomeLoss	-3216714
CY2019Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11959
CY2018Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6994
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-22402
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-108657
CY2019Q2	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
	us-gaap	Open Tax Year OpenTaxYear	2015 2016 2017
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	2613499
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	2831612
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1424687
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1926015
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3426340
CY2019Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	39554
	us-gaap	Operating Lease Cost OperatingLeaseCost	79109
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	166292
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	92830
CY2019Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	92830
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent
	us-gaap	Operating Lease Payments OperatingLeasePayments	79109
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	166292
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	92830
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset
CY2019Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.092
CY2019Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P21D
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	175557
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four And Five Years OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two And Three Years OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears	16419
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	159138
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17355
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26878
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2563
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1756
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4825
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3457
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	7000
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	7000
CY2019Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	7
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	406563
CY2019Q2	us-gaap	Share Price SharePrice	0.36
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	82557
CY2019Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2257851
CY2018Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2428498
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4173759
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4234103
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	414541
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman"; font-size: 9pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.</div>  Reclassifications</div></div> <div style=" font-family: "Times New Roman"; font-size: 9pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: "Times New Roman"; font-size: 9pt; margin: 0pt; text-align: left;">Certain reclassifications have been made to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> financial statements to conform to the condensed  consolidated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> financial statement presentation. These reclassifications had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on net loss or cash flows as previously reported.</div></div></div>
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1974547
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2019Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
CY2014Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000000
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement
	us-gaap	Profit Loss ProfitLoss	-1846437
	us-gaap	Profit Loss ProfitLoss	-3325371
CY2019Q2	us-gaap	Profit Loss ProfitLoss	-1053243
CY2018Q2	us-gaap	Profit Loss ProfitLoss	-1350001
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-793195
CY2018Q1	us-gaap	Profit Loss ProfitLoss
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	65668
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	95529
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9775
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	101875
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	235592
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-87823965
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85999929
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2517970
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2821837
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4627023
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5840601
	us-gaap	Share Based Compensation ShareBasedCompensation	101700
	us-gaap	Share Based Compensation ShareBasedCompensation	170901
	us-gaap	Stock Issued1 StockIssued1
	us-gaap	Stock Issued1 StockIssued1	286602
CY2018Q2	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	286602
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7500
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000
CY2018Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	37500
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	871236
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1539610
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1528208
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2726502
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	837432
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7500628
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5951567
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5319509
CY2019Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2019Q2	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman"; font-size: 9pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.</div>  Use of Estimates</div></div> <div style=" font-family: "Times New Roman"; font-size: 9pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman"; font-size: 9pt; margin: 0pt; text-align: left;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to the allowance for doubtful accounts, inventory valuation, and cash flow assumptions regarding evaluations for impairment of long-lived assets and going concern considerations, and valuation allowances on deferred tax assets. Actual results could differ from those estimates<div style="display: inline; font-weight: bold;">.</div></div></div></div>
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45366237
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35297906
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41904581
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34939306
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45366237
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35297906
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41904581
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34939306

Files In Submission

Name	View Source	Status
0001437749-19-016799-index-headers.html	Edgar Link	pending
0001437749-19-016799-index.html	Edgar Link	pending
0001437749-19-016799.txt	Edgar Link	pending
0001437749-19-016799-xbrl.zip	Edgar Link	pending
ex_146651.htm	Edgar Link	pending
ex_146652.htm	Edgar Link	pending
ex_146653.htm	Edgar Link	pending
ex_146654.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mlss-20190630.xml	Edgar Link	completed
mlss-20190630.xsd	Edgar Link	pending
mlss-20190630_cal.xml	Edgar Link	unprocessable
mlss-20190630_def.xml	Edgar Link	unprocessable
mlss-20190630_lab.xml	Edgar Link	unprocessable
mlss-20190630_pre.xml	Edgar Link	unprocessable
mlss20190630_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

2019 Q2 Form 10-Q Financial Statement

#000143774919016799 Filed on August 14, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS MILESTONE SCIENTIFIC INC. Stock $mlss

2019 Q2 Form 10-Q Financial Statement

#000143774919016799 Filed on August 14, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss